Search
forResearch 10 of 402
- Use of cyproterone acetate (CPA) in the treatment of acne, hirsutism and virilism
- Obesity and Polycystic Ovary Syndrome: Implications for Pathogenesis and Novel Management Strategies
- Non-classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency revisited: an update with a special focus on adolescent and adult women
- Treatment of Obstructive Sleep Apnea Improves Cardiometabolic Function in Young Obese Women with Polycystic Ovary Syndrome
- Cyproterone acetate for severe hirsutism:results of a double‐blind dose‐ranging study*
- Polycystic Ovary Syndrome: Update on Diagnosis and Treatment
- Risk of meningioma among users of high doses of cyproterone acetate as compared with the general population: evidence from a population-based cohort study
- The importance of adequate serum ferritin levels during oral cyproterone acetate and ethinyl oestradiol treatment of diffuse androgen-dependent alopecia in women
- Treatment of hirsutism: comparisons between different antiandrogens with central and peripheral effects
- A comparison of the relative efficacy of antiandrogens for the treatment of acne in hyperandrogenic women
Community 4
Learn
— no results
Try a deeper search in learn →